ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb(R) here.
Synonyms: Antigen KI-67; Antigen Ki67; Antigen identified by monoclonal antibody Ki-67; Proliferation marker protein Ki-67
Storage: 2-8C
Application: Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected Ki67 in HUVEC, HeLa, and A431 cells.Immunohistochemistry (Paraffin) Analysis: A 1:400 dilution from a representative lot detected Ki67 in human tonsil and human skin tissue sections.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany